Bausch Health to Participate in RBC Capital Markets 2026 Global Healthcare Conference
Rhea-AI Summary
Bausch Health (NYSE:BHC) announced that CEO Thomas J. Appio and EVP/CFO Jean-Jacques Charhon will join a fireside chat at the RBC Capital Markets 2026 Global Healthcare Conference in New York City on May 20, 2026, at 9:30 a.m. U.S. ET.
A live audio webcast and replay will be available in the Investor Relations section of Bausch Health's website.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – BHC
On the day this news was published, BHC declined 2.22%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
BHC was up 0.74% while several peers were down (e.g., ALVO -1.11%, HCM -1.55%, AMRX -1.41%), with SUPN the main gainer at +1.85%, suggesting stock-specific factors rather than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Apr 29 | Q1 2026 earnings | Neutral | +2.3% | Reported higher revenue and adjusted EPS but large goodwill impairment-driven loss. |
| Apr 14 | Product launch | Positive | -0.7% | Launched Biafine Skin Recovery Emulsion for U.S. consumers via online channels. |
| Mar 31 | Earnings date notice | Neutral | +7.4% | Announced timing of Q1 2026 results release and related conference call. |
| Mar 26 | Scholarship program | Neutral | +0.8% | Announced 2026 ASPIRE HIGHER dermatology scholarship awards up to $10,000 each. |
| Feb 23 | Aesthetics launch | Positive | -2.5% | Introduced Clear + Brilliant Touch laser in Canada after prior Health Canada approval. |
Recent history shows mixed reactions, with several positive or neutral announcements followed by divergent price moves, especially around product launches and event notices.
Over the last few months, Bausch Health reported Q1 2026 results on Apr 29, with revenue of $2.52 billion, a large goodwill impairment, and reaffirmed 2026 guidance. Earlier, the company issued an earnings date announcement on Mar 31 that preceded a 7.36% move. Other updates included product launches in dermatology and aesthetics and a scholarship program. Today’s investor conference participation fits into this pattern of regular corporate communications and investor outreach.
Market Pulse Summary
This announcement highlights Bausch Health’s participation in a major healthcare conference, offering management a platform to engage with investors via a 9:30 a.m. U.S. ET fireside chat and webcast on May 20, 2026. Set against recent Q1 2026 results, goodwill impairment, and ongoing product launches, the event adds to regular outreach rather than changing fundamentals. Investors may focus on management commentary around strategy, balance sheet, and execution progress discussed at the conference.
AI-generated analysis. Not financial advice.
Details
Date: Wednesday, May 20, 2026
Time: 9:30 a.m.
Webcast: http://ir.bauschhealth.com/events-and-presentations
A replay of the event will be available on the investor relations website following the event.
About Bausch Health
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global, diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neuroscience, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb Corporation. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information about Bausch Health, visit www.bauschhealth.com and connect with us on LinkedIn.
Forward-looking Statements
This news release may contain forward-looking statements within the meaning of applicable securities laws, including the Safe Harbor provisions of the
Investor Contact: | Media Contact: |
Garen Sarafian | Katie Savastano |
(877) 281-6642 (toll free) | (908) 569-3692 |
BHC-FINANCIAL |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch-health-to-participate-in-rbc-capital-markets-2026-global-healthcare-conference-302770039.html
SOURCE Bausch Health Companies Inc.
